Breaking News, Collaborations & Alliances

Biomunex Pharmaceuticals Embraces AI with Two New Strategic Collaborations

Aims to further accelerate the discovery and development processes of novel immunotherapeutic approaches in oncology.

Author Image

By: Charlie Sternberg

Associate Editor

Biomunex Pharmaceuticals, a biopharmaceutical company specialized in the discovery and development of innovative immunotherapies based on bispecific and multi-specific antibodies, has announced two new strategic collaborations with AI-driven companies—Gordion Bioscience and Tangramed Biotech—to further integrate relevant AI into all its scientific processes. The goal is to further accelerate the discovery and development processes of novel immunotherapeutic approaches in oncology. Under the f...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters